Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
55 Cards in this Set
- Front
- Back
site of androgen synthesis?
|
reticulans
|
|
site of cortisol synthesis?
|
fasciculata
|
|
site of aldosterone synthesis?
|
glomerulosa
|
|
chemical differences between adrenal steroids?
|
minor oxidation points but these differences have major effects
|
|
mechanism of action of adrenal steroids?
|
bind to chaperone proteins
work as trxn factors direct alteration of gene products each cell has 10-100 GCC-responsive genes |
|
why do adrenal steroids have so many effects?
|
each cell has 10-100 GCC-responsive genes
|
|
effects of GCC on metabolism?
|
stimulates hepatic glucose formation
diminish glucose utilization in periphery |
|
hepatic glucose formation from?
|
glycerol (gluconeogenesis)
amino acids |
|
how do GCC diminish glucose utilization in periphery?
|
enhance protein catabolism in muscle
enhance lipolysis in fat |
|
end/side effects of GCC?
|
increase plasma glucose (steroid diabetes);
fat mobilization leading to accumulation at 'trunk'; muscle wasting (at high doses) |
|
antiinflammatory effects of GCC?
|
inhibit synthesis of leukotrienes, PGs;
decrease cellular content and release of histamine; decrease the synthesis of interleukins and cytokines; decrease the synthesis of MCF, MAF; decrease activity of MIF; decrease the release of lytic enzymes; decrease release of reactive O2 products |
|
MCC mechanism?
|
increase Na+ reuptake creating positive Na+ balance;
increase extracellular fluid volume |
|
high levels of MCC result in?
|
increased blood pressure
hypokalemia hypernatremia alkalosis |
|
low levels of MCC result in?
|
decreased blood pressure
hyperkalemia hyponatremia acidosis |
|
uses of synthetic adrenocorticosteroids?
|
replacement therapy
antiinflammatory therapy immunosuppressive therapy diagnostic purposes |
|
major goals of medicinal chemist?
|
develop synthetic corticosteroids
separate MCC, GCC actions |
|
relative potencies of:
prednisolone 9α-fluorocortisol dexamethasone |
prednisolone: 4xGCC; 0.5xMCC
9α-fluorocortisol: 10xGCC; 125xMCC dexamethasone; 30xGCC; 0xMCC |
|
addison's disease?
|
primary adrenal insufficiency;
autoimmune in 70-80% |
|
causes of addison's disease?
|
autoimmune
TB and other infections surgery |
|
treatment for addison's disease?
|
replacement therapy with cortisol;
usually sufficient for GCC and MCC activity; MCC supplement may be required |
|
fludrocortisone?
|
MCC supplement
|
|
how is replacement dose of cortisol given?
|
2/3 in morning and 1/3 in late afternoon to mimic the normal pattern
|
|
what may require dose adjustment of cortisol?
|
illness or stress usually requires 2-3 times normal dose
|
|
most common enzyme deficiency?
|
21 hydroxylase
|
|
how can cortisol levels be normal when there is an enzyme deficiency?
|
compensatory increase in ACTH that causes adrenal hyperplasia resulting in normal cortisol concentration
|
|
consequence of most adrenal enzyme deficiencies?
|
increased androgen secretion because their production doesn't require the deficient enzymes and more cholesterol is shunted into the alternate pathways
|
|
treatment for adrenal enzyme deficiencies?
|
100 mg/day initially (~5 days) to decrease ACTH production;
then reduced to replacement therapy levels |
|
toxicity of GCC steroids?
|
CNS effects (euphoria)
steroid diabetes skeletal effects increased infectivity ulcers delayed wound healing adrenal atrophy |
|
CNS effects of GCC?
|
may produce a euphoria that makes it difficult to wean the patient
|
|
skeletal effects of GCC?
|
osteoporosis develops due to decreased Ca2+ absorption with resulting increased PTH and bone resorption
|
|
therapy approach to circumvent adrenal atrophy?
|
alternate-day steroid therapy using double the daily dose
|
|
benefits of alternate-day steroid therapy?
|
adrenals do not atrophy
stress response remains normal other side effects are decreased |
|
causes of cushings?
|
pituitary adenoma
nonendocrine tumors secreting ACTH (metastatic cancer) abnormal adrenal gland responses (hyperplasia) ectopic adrenal tissue (mets from adrenal tumor) |
|
true cushing's disease?
|
pituitary adenoma secreting ACTH
|
|
dexamethasone suppression test?
|
low dose turns off ACTH in normal;
4x needed in cushing dz; not turned off with high dose then suspect cancer |
|
diagnosis of cushings?
|
urinary free cortisol test (>50-100 mg/day)
dexamethasone suppression test petrosal sinus testing |
|
petrosal sinus testing?
|
blood sample from veins directly draining pituitary;
CRH give and ACTH measured; compare with peripheral venous blood; tell if ACTH is coming from pit or ectopic location |
|
signs of GCC/MCC excess?
|
truncal obesity
muscle wasting steroid diabetes bone demineralization growth retardation CNS manifestations HTN delayed wound healing hypokalemic alkalosis |
|
signs of androgen excess?
|
hirsutism
amenorrhea |
|
treatment of cushings?
|
pharmacological intervention until make diagnosis;
then remove source of ACTH |
|
why is pharmacological treatment of cushings best utilized as bridging therapy to ablation?
|
although decrease cortisol production this results in more ACTH;
therapeutic effects can be overridden; upregulation of other corticosteroids |
|
mitotane?
|
adrenostatic drug
derivative of DDT reacts nonspecifically with hydroxylases destroys tissue (so ACTH does not overcome) removed from US market |
|
amphenone B?
|
adrenostatic drug
more potent derivative of mitotane blocks hydroxylases does not destroy tissue (ACTH leads to hypertrophy) removed from US market |
|
metyrapone?
|
adrenostatic drug
specific inhibitor of 11β hydroxylase rarely used as therapy used in cortisol excess before known cause; test for pituitary reserve of ACTH |
|
aminoglutethimide?
|
adrenostatic drug
inhibits cholesterol --> pregnenolone reduces MCC, GCC, androgen secretion not specific to adrenal overcome by ACTH used with dex to decrease androgen synthesis |
|
used primarily for cushings syndrome secondary to adrenal cancer?
|
aminoglutethimide
|
|
used to test of pituitary reserve of ACTH?
|
metyrapone
|
|
ketoconazole?
|
adrenostatic drug;
blocks many of steroid synthesis P450s; displace estrogen, testosterone from binding proteins; increases estrogen:testosterone ratio |
|
side effects of ketoconazole?
|
compensatory increase in ACTH --> increased androgens and aldosterone;
increased estrogen:testosterone ratio --> gynecomastia and oligospermia in males and altered menstrual cycle in females |
|
mifepristone (RU486)?
|
GCC receptor antagonist
|
|
spironolactone?
|
MCC receptor antagonist
|
|
spironolactone use in cushings?
|
treats excessive aldosterone secretion
|
|
captopril?
|
ACE inhibitor
|
|
losartan?
|
ARB
|
|
other mechanisms of treatment?
|
GCC receptor antagonist
MCC receptor antagonist ACEI ARBs |